The Pediatric Onco-Hematology Unit of the HM Group, led by Dr. Blanca López-Ibor, M.D., is part of he Montepríncipe HM University Hospital, in Boadilla del Monte, Madrid. It shares its technical and human infrastructure with the CIOCC (Clara Campal Oncological Integral Center) and with HM Hospitals. It was opened on October 2nd, 2006 and is the result of the interest of Dr. Carmen Cidón and Dr. Juan Abarca in joining the services of a tertiary hospital with the specific care of children and teenagers who have been diagnosed with cancer or other severe oncological diseases.
Who do we take care of?
We take care of children and teenagers from 0 to 18 years old from all health insurance companies as well as from civil service mutual services (MUFACE, MUGEJU) and private patients.
Diseases we treat
We treat hematological and oncological diseases.
We take care of children and teenagers from 0 to 18 years old from all health insurance companies as well as from civil service mutual services (MUFACE, MUGEJU) and private patients.
What is our philosophy?
Children and their families constitute the focus of our work.
Multidisciplinary team: With a team of qualified professionals who follow current therapeutic guidelines and with the goal of minimizing the side-effects and the complications that derive from treatment. Team
Availability: We are available 24 hour a day, 365 days a year. CONTACT
Comprehensive healthcare: We integrate the disease into the ordinary life of children and families from a physical, psychological, social and spiritual point of view. Psychosocial
Objectives and results
- Achieving the highest possible healing ratio. Minimizing side-effects and complications of treatment.
- Coordinate the work of the entire team of professionals staff work in a coordinated manner so that the child receives the diagnostic and therapeutic services he/she needs at any given moment.
- Utilizing the latest scientific and technological advances and transfer them to the clinical practice.
- Integrating the disease into the daily life of children and families.
- Providing a comprehensive care of children, ensuring their medical, psychological, social and spiritual wellbeing during the treatment.
After more than 25 years of experience in treating childhood cancer, the results in terms of survival are comparable to those from the Spanish Register, as is seen in the upper chart.
The bottom chart shows the improvement in childhood cancer survival in the past 30 years.
What do we do it for?
Our goal is not only to achieve the highest possible healing ratio but also that survivors of childhood cancer become healthy adults in the four area of the human being: physical, psychological, social and spiritual.
Scientific publications (last 10 years)
- Case of Refractory Classic Hodgkin Lymphoma With a Germline Pathogenic Monoallelic Variant in the TNFRSF13B Gene. Pediatric Blood & Cancer. 03/2025. DOI: 10.1002/pbc.31505
- Cancer Predisposition Syndromes in Children: Who, How, and When Should Genetic Studies Be Considered? Journal of Pediatric Hematology/Oncology. 11/2024. DOI: 10.1097/MPH.0000000000002932
- Palliative care for children with central nervous system tumors: results of a Spanish multicenter study. Clinical & translational oncology. 2024. DOI: 10.1007/s12094-023-03301-7
- Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors. Quantitative Imaging in Medicine and Surgery. 11/2024. DOI: 10.21037/qims-24-621
- A Scoping Review of Focused Ultrasound Enhanced Drug Delivery for Across the Blood–Brain Barrier for Brain Tumors. Operative Neurosurgery. 11/2024. DOI: 10.1227/ons.0000000000001175
- Pediatric Palliative Radiotherapy. Authorea. 01/2024. DOI: 10.22541/au.170668076.62982687/v1
- Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities. Pediatric Blood & Cáncer. 2024. DOI: 10.1002/pbc.31120
- Clinical experience with immunotherapy in patients with diffuse intrinsic pontine glioma. European journal of hospital pharmacy. 2023 DOI: 10.1136/ejhpharm-2022-003511
- Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population. Hematological oncology. 2023. DOI: 10.1002/hon.3131
- Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review. Frontiers in oncology. 2023. DOI: 10.3389/fonc.2023.1229853
- Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma. The New England journal of medicine. 06/2022. DOI: 10.1056/nejmoa2202028
- Family-centered palliative care in pediatric oncology. Apuntes de Bioetica. 2022. ISSN-e 2663-4910
- Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries - A study by the Joint Action on Rare Cancers. Cancer epidemiology. 2022. DOI: 10.1016/j.canep.2022.102145
- Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort. 08/2022. DOI: 10.1007/s10067-022-06319-4
- Unexpected Cause of Persistent Microcytosis and Neurological Symptoms in a Child: Niemann-Pick Disease Type C. Journal of Pediatric Hematology/Oncology 11/2021. DOI: 10.1097/MPH.0000000000002135
- The importance of Li-Fraumeni syndrome, a hereditary cancer predisposition disorder. Archivos argentinos de pediatría. 02/2021. DOI: 10.5546/aap.2021.eng.e11
- Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease. 09/2021. DOI: 10.1016/j.jpeds.2021.05.023
- Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review. Frontiers in genetics. 2021. DOI: 10.3389/fgene.2021.749480
- Validation of the anthropometric data reported by parents of participants in the SENDO project. Nutrición Hospitalaria. 2021. DOI: 10.20960/nh.03621
- Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children. New England Journal of Medicine. 06-2020. DOI: 10.1056/nejmoa1915315
- Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). British Journal of Haematology. 09/2020. DOI: 10.1111/bjh.16647
- Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. Journal of hepatology. 2020. DOI: 10.1016/j.jhep.2020.03.025
- Oncolytic viral therapy with anti-PD-1 immunotherapy in a pediatric patient with diffuse intrinsic pontine glioma. Pediatric Hematology Oncology Journal. 09/2020. DOI: 10.1016/j.phoj.2020.06.014
- A school in a Pediatric Oncology Unit: The crucial role of Education in the context of serious illness. Educare. 2020. DOI: 10.15359/ree.24-1.5.
- Bioetica clinica: la mujer ante los retos de la bioretica actual. Apuntes de Bioetica. 2020. DOI: 10.35383/apuntes.v3i2.497
- Curar a un niño, no solo a su enfermedad. Psicooncologia. 2020.
- Severe Cardiac and Abdominal Manifestations Without Lung Involvement in a Child With COVID-19. International Journal of Clinical Pediatrics. 2020. DOI: 10.14740/ijcp387
- BRAFV600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors. Cancers. 12/2019. DOI: 10.3390/cancers12010066
- Coping with Incongruence: Mirror Therapy to Manage the Phantom Limb Phenomenon in Pediatric Amputee Patients. Journal of pain and symptom management. 2019. DOI: 10.1016/j.jpainsymman.2018.10.495
- Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study. Annals of the Rheumatic Diseases. 02/2019. DOI: 10.1136/annrheumdis-2018-213891
- Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nature communications. 2018. DOI:
- Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology. 2018. DOI:
- When a transfusion in an emergency service is not really urgent: Hyperhaemolysis syndrome in a child with sickle cell disease. BMJ Case Reports. 2018. DOI: 10.1136/bcr-2017-223209
- Isolated intra-axial central nervous system juvenile xanthogranuloma (JXG). Clinical management and follow-up with PET-MRI. Pediatric Hematology and Oncology Journal. 2018. DOI: 10.1016/j.phoj.2017.12.003
- Pediculosis capitis: Is it really an insignificant disease? Pediatria de Atencion Primaria 2016. ISSN | 2174-4106
- All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of hematology. 2015. DOI: 10.1007/s00277-015-2393-0
- Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet (London, England). 2015. DOI: 10.1016/s0140-6736(14)62395-3
Chapters of Books
- Lo humano en cuestión. Scripta Theologica. 53 - 1, pp. 233 - 236. Didaskalos, 2021.
- Vivir sin pensar: sentimiento toxico y bioetica. IBSN 8490619409. Palabra, 11/2019.
- Oncología Pediátrica y Musicoterapia. Musicoterapia in oncologia e nelle cure palliative. pp. 74 - 93. Francoangeli/Sanita, 2015 y 2020
- Oncología Pediátrica. Un modelo de hospital. pp. 90 - 115. Abarca Cidon y Perez Iñigo, 2011
- Atención al niño y adolescente con cáncer. In Estrategia contra el Cáncer del Sistema Nacional de Salud, Plan de Calidad para el sistema Nacional de Salud, Ministerio de Sanidad y Consumo. 2006
- Neuroblastoma.In Tratado de Oncologia Pediatrica. L. Sierrasesumaga. pp. 215 - 230. Interamericana McGraw, Hill. 2005
- Tumores de la cresta neural. In Hematologia y Oncologia Pediatrica. L. Madero, pp. 501- 520. Ergon, 1997.
- Biología Molecular del Cáncer infantil. In Oncología Pediátrica. L. Sierrasesumaga. pp. 21 - 35. Interamericana McGraw, 1992.
- Leucemia Aguda No linfoblástica. In Oncología Pediátrica. L. Sierrasesumaga. pp. 21 - 35. Interamericana McGraw, 1992.